Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 1/20 | 0.34 |
| ▸ | IDO1 | P14902 | 1/20 | 0.33 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | PDE10A | Q9Y233 | 3/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | ACVR1 | Q04771 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.30 |
| ▸ | ATM | Q13315 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | COMT | P21964 | 1/20 | 0.30 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.30 |
| ▸ | GPR3 | P46089 | 1/20 | 0.30 |
| ▸ | PIM1 | P11309 | 1/20 | 0.30 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18232839 | 0.96 | LIMK1 (0.35) | ALOX5IDO1LIMK1ACHEHTT | |
| SCHEMBL18232873 | 0.95 | ALOX5 (0.33) | ALOX5IDO1LIMK1ACHEPDE10A | |
| SCHEMBL18232856 | 0.89 | KDM4E (0.36) | ALOX5LIMK1ACHEPDE10AACVR1 | |
| SCHEMBL18232832 | 0.87 | KDM4E (0.34) | ALOX5LIMK1ACHEALDH1A1ACVR1 | |
| SCHEMBL18232938 | 0.85 | CCR1 (0.33) | LIMK1HTTCOMTNPY5RPIM1 | |
| SCHEMBL18232834 | 0.85 | LIMK1 (0.39) | LIMK1ACHEALDH1A1KDM4EATM | |
| SCHEMBL18232842 | 0.85 | ALOX5 (0.39) | ALOX5IDO1LIMK1ACHEHTT | |
| SCHEMBL25105927 | 0.85 | ALOX5 (0.43) | ALOX5ALDH1A1KDM4EATML3MBTL1 | |
| SCHEMBL18232870 | 0.83 | LIMK1 (0.38) | LIMK1ACHEALDH1A1KDM4EATM | |
| SCHEMBL18232901 | 0.82 | LIMK1 (0.37) | LIMK1ACHEALDH1A1KDM4EATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160336517-A1 | Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-11-17 | — | — | US | disclosed |
| US-20160336517-A1 | Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2016-11-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160336517-A1 | Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device, and Lighting Device | NR2E3, LEF1, LAGE3 | ALOX5 554/4885IDO1 1060/4885LIMK1 145/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.